Web21 okt. 2024 · About Keros Therapeutics, Inc. Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel … WebKeros Therapeutics Powered by TGF-β science, inspired by patients At Keros, our mission is to innovate therapies that have the potential to shift the treatment paradigm for people … At Keros, our mission is to deliver significant clinical benefit to patients suffering from … At Keros, we are leveraging ... we have honed a deep understanding of TGF-β … The Investor Relations website contains information about Keros Therapeutics's … Careers - Keros Therapeutics Contact Us - Keros Therapeutics Ran Nussbaum has served as Chairman of our board of directors since April … Christopher Rovaldi has served as our Chief Operating Officer since February … Our Pipeline - Keros Therapeutics
Analyst Coverage Keros Therapeutics
Web5 nov. 2024 · The ability of KER-050 to target multiple stages along the erythropoiesis cascade makes it an appealing therapeutic candidate for diseases that cause anemia due to ineffective erythropoiesis, including MDS and MF, where defects can arise throughout the erythropoietic pathway. Disclosures Feigenson:Keros Therapeutics: Current Employment. Web10 nov. 2024 · Keros’ lead protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes and … number one aldwych hotel
Why Shares of Keros Therapeutics Rose 10.2% This Week
Web2 aug. 2024 · LEXINGTON, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and... Web13 jun. 2024 · About Keros Therapeutics, Inc. Keros is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel … Web3 okt. 2024 · Promising hypertension pipeline therapies in various stages of development include Firibastat, Baxdrostat (CIN-107), MLS-101, Zilebesiran (ALN-AGT), Ifetroban, IONIS-AGT-LRx, QLS-101, ID140009,... number one and number two